MX2010002765A - Derivado de 6-pirimidinil-pirimid-4-ona. - Google Patents
Derivado de 6-pirimidinil-pirimid-4-ona.Info
- Publication number
- MX2010002765A MX2010002765A MX2010002765A MX2010002765A MX2010002765A MX 2010002765 A MX2010002765 A MX 2010002765A MX 2010002765 A MX2010002765 A MX 2010002765A MX 2010002765 A MX2010002765 A MX 2010002765A MX 2010002765 A MX2010002765 A MX 2010002765A
- Authority
- MX
- Mexico
- Prior art keywords
- pyrimid
- pyrimidinyl
- derivative
- preventive
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Un compuesto representado por la fórmula (I) o una sal farmacéuticamente aceptable de él: (ver fórmula (I)) que se usa para el tratamiento preventivo y/o terapéutico de una enfermedad provocada por la actividad anormal de la tau proteína cinasa 1 tal como enfermedades neurodegenerativas (por ejemplo, la enfermedad de Alzheimer).
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007269485 | 2007-09-14 | ||
JP2007275713 | 2007-09-25 | ||
EP08290028A EP2078717A1 (en) | 2008-01-11 | 2008-01-11 | 6-Pyrimidinyl-pyrimid-2-one derivative |
PCT/JP2008/066936 WO2009035162A1 (en) | 2007-09-14 | 2008-09-12 | 6-pyrimidinyl-pyrimid-2-one derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010002765A true MX2010002765A (es) | 2010-05-19 |
Family
ID=39874051
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010002765A MX2010002765A (es) | 2007-09-14 | 2008-09-12 | Derivado de 6-pirimidinil-pirimid-4-ona. |
Country Status (15)
Country | Link |
---|---|
US (2) | US8198437B2 (es) |
EP (1) | EP2193129B1 (es) |
JP (1) | JP5249320B2 (es) |
KR (1) | KR20100074182A (es) |
CN (1) | CN101883770A (es) |
AR (1) | AR068439A1 (es) |
AU (1) | AU2008297817A1 (es) |
BR (1) | BRPI0816705A2 (es) |
CA (1) | CA2698819A1 (es) |
EA (1) | EA201070367A1 (es) |
MX (1) | MX2010002765A (es) |
NZ (1) | NZ584277A (es) |
TW (1) | TW200927134A (es) |
WO (1) | WO2009035162A1 (es) |
ZA (1) | ZA201002213B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW200813015A (en) * | 2006-03-15 | 2008-03-16 | Mitsubishi Pharma Corp | 2-(cyclic amino)-pyrimidone derivatives |
BRPI0816705A2 (pt) | 2007-09-14 | 2015-03-17 | Mitsubishi Tanabe Pharma Corp | Derivatido de 6-pirimidinil-pirimid-2-ona |
TW201043618A (en) | 2009-03-10 | 2010-12-16 | Sanofi Aventis | Intermediate compound for synthesizing pharmaceutical agent and production method thereof |
US8940738B2 (en) | 2009-08-13 | 2015-01-27 | Mitsubishi Tanabe Pharma Corporation | Pyrimidone compounds |
EP2464632A1 (en) | 2009-08-13 | 2012-06-20 | Mitsubishi Tanabe Pharma Corporation | Pyrimidone derivatives used as tau protein kinase 1 inhibitors |
EP2567959B1 (en) | 2011-09-12 | 2014-04-16 | Sanofi | 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors |
EP3453706A1 (en) | 2017-09-08 | 2019-03-13 | Basf Se | Pesticidal imidazole compounds |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2116460A1 (en) | 1993-03-02 | 1994-09-03 | Mitsubishi Chemical Corporation | Preventive or therapeutic agents for alzheimer's disease, a screening method of alzheimer's disease and tau-protein kinase i originated from human being |
WO2003037888A1 (en) * | 2001-09-21 | 2003-05-08 | Mitsubishi Pharma Corporation | 3-substituted-4-pyrimidone derivatives |
AU2002337498B2 (en) | 2001-09-21 | 2006-08-10 | Mitsubishi Pharma Corporation | 3-substituted-4-pyrimidone derivatives |
TWI357408B (en) * | 2003-03-26 | 2012-02-01 | Mitsubishi Tanabe Pharma Corp | 3-substituted-4-pyrimidone derivatives |
AR050865A1 (es) * | 2004-09-09 | 2006-11-29 | Sanofi Aventis | Derivados de 2- morfolino-4-pirimidona |
AR051823A1 (es) | 2004-09-29 | 2007-02-14 | Mitsubishi Pharma Corp | Derivados de piridinil-pirimidonas |
TW200740779A (en) | 2005-07-22 | 2007-11-01 | Mitsubishi Pharma Corp | Intermediate compound for synthesizing pharmaceutical agent and production method thereof |
TW200813015A (en) * | 2006-03-15 | 2008-03-16 | Mitsubishi Pharma Corp | 2-(cyclic amino)-pyrimidone derivatives |
AR064660A1 (es) * | 2006-12-26 | 2009-04-15 | Mitsubishi Tanabe Pharma Corp | Derivados de pirimidinona 6-heterociclica 2-sustituida, medicamentos que los contienen y usos para prevenir y/o tratar enfermedades neurodegenerativas entre otras |
BRPI0816705A2 (pt) | 2007-09-14 | 2015-03-17 | Mitsubishi Tanabe Pharma Corp | Derivatido de 6-pirimidinil-pirimid-2-ona |
AR076014A1 (es) | 2009-04-02 | 2011-05-11 | Sanofi Aventis | Derivados de 3- (1,4) oxazepan -4-pirimidona |
-
2008
- 2008-09-12 BR BRPI0816705 patent/BRPI0816705A2/pt not_active IP Right Cessation
- 2008-09-12 US US12/677,213 patent/US8198437B2/en not_active Expired - Fee Related
- 2008-09-12 EP EP08831179A patent/EP2193129B1/en active Active
- 2008-09-12 CA CA2698819A patent/CA2698819A1/en not_active Abandoned
- 2008-09-12 KR KR1020107008065A patent/KR20100074182A/ko not_active Application Discontinuation
- 2008-09-12 TW TW097135175A patent/TW200927134A/zh unknown
- 2008-09-12 JP JP2010510582A patent/JP5249320B2/ja not_active Expired - Fee Related
- 2008-09-12 EA EA201070367A patent/EA201070367A1/ru unknown
- 2008-09-12 MX MX2010002765A patent/MX2010002765A/es not_active Application Discontinuation
- 2008-09-12 AU AU2008297817A patent/AU2008297817A1/en not_active Abandoned
- 2008-09-12 AR ARP080103982A patent/AR068439A1/es not_active Application Discontinuation
- 2008-09-12 WO PCT/JP2008/066936 patent/WO2009035162A1/en active Application Filing
- 2008-09-12 CN CN2008801137447A patent/CN101883770A/zh active Pending
- 2008-09-12 NZ NZ584277A patent/NZ584277A/en not_active IP Right Cessation
-
2010
- 2010-03-29 ZA ZA2010/02213A patent/ZA201002213B/en unknown
-
2012
- 2012-05-09 US US13/467,302 patent/US8518939B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AR068439A1 (es) | 2009-11-18 |
BRPI0816705A2 (pt) | 2015-03-17 |
CA2698819A1 (en) | 2009-03-19 |
US8198437B2 (en) | 2012-06-12 |
JP2010538969A (ja) | 2010-12-16 |
NZ584277A (en) | 2011-11-25 |
JP5249320B2 (ja) | 2013-07-31 |
CN101883770A (zh) | 2010-11-10 |
EA201070367A1 (ru) | 2010-08-30 |
TW200927134A (en) | 2009-07-01 |
WO2009035162A1 (en) | 2009-03-19 |
EP2193129B1 (en) | 2012-10-24 |
US20120252812A1 (en) | 2012-10-04 |
ZA201002213B (en) | 2011-06-29 |
KR20100074182A (ko) | 2010-07-01 |
US8518939B2 (en) | 2013-08-27 |
US20110021773A1 (en) | 2011-01-27 |
AU2008297817A1 (en) | 2009-03-19 |
EP2193129A1 (en) | 2010-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2261224A3 (en) | 6-(Pyridinyl)-4-pyrimidone derivatives as tau protein kinase 1 inhibitors | |
MX2010002765A (es) | Derivado de 6-pirimidinil-pirimid-4-ona. | |
UA93872C2 (ru) | Дигидротиенопиримидины для лечения воспалительных заболеваний | |
NO20064726L (no) | Imidazolforbindelser for behandling av neurodegenerative forstyrrelser | |
NO20090025L (no) | Pyrrolotriazinkinaseinhibitorer | |
BRPI0513433A (pt) | derivados de hidantoìna para o tratamento de distúrbios inflamatórios | |
MX2009006947A (es) | Derivados de pirimidona 6-heterociclica 2-sustituida. | |
NO20052223L (no) | Tiazolforbindelser for behandling av neurodegenerative forstyrrelser | |
AR068438A1 (es) | Derivado de 6-pirimidinil-pirimid-2-ona | |
UA109698C2 (xx) | Похідні азаіндазолу або діазаіндазолу як медикамент | |
MX2008013212A (es) | 4-anilinquinolina-3-carboxamidas como inhibidores de la cinsa csf-1r. | |
TW200621760A (en) | 2-morpholino-4-pyrimidone compound | |
WO2008130879A3 (en) | Tetrahydroindole and tetrahydroindazole derivatives | |
UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
WO2006081431A3 (en) | Compounds for treating inflammatory and demyelinating diseases | |
WO2009025785A3 (en) | Cb2 receptor ligands for the treatment of pain | |
WO2007009723A3 (en) | Azepane- or azocane-substituted pyrazoline derivatives, their preparation and use as medicaments | |
JO2629B1 (en) | Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon | |
EA201270359A1 (ru) | Терапевтическое средство от расстройств настроения | |
NO20064989L (no) | Sulfonamidforbindelser for behandling av neurodegenerative lidelser | |
PH12019502652A1 (en) | 5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases | |
NO20074617L (no) | Nye forbindelser for behandling av inflamotoriske sykdommer | |
WO2011159124A3 (ko) | Interleukin-6 억제 작용을 갖는 신규한 벤즈옥사졸 유도체, 이의 제조 방법 및 이를 포함하는 약학적 조성물 | |
RS20080139A (en) | Imidazole coumpounds for the treatment of neurological disorders | |
EA201070898A1 (ru) | Новое производное хиназолин-2,4-диона и лекарственные композиции на его основе для профилактики и лечения заболевания, обусловленного поражением черепно-мозгового нерва |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |